KPTI vs ZION · rev $68.5M vs P/E 11, rev $354.0M
Karyopharm Therapeutics Inc (KPTI) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
KPTI currently screens at market cap $205.6M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the KPTI and ZION stock pages for the full models.
Not investment advice.